SEC Form 4 · accession 0001179110-18-003667
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Goldstein
Director
Period of report
Mar 2, 2018
Accepted (ET)
Mar 6, 2018 · 5:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 2, 2018 | M | 54,325 | $8.71 | A | 54,325 | D | |
| Common Stock | Mar 2, 2018 | M | 12,249 | $10.84 | A | 66,574 | D | |
| Common Stock | Mar 2, 2018 | S | 66,574 | $39.72 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $8.71 | Mar 2, 2018 | M | 54,325 | D | — | Feb 25, 2025 | Common Stock | 54,325 | 33,605 | D |
| Stock Option (right to buy)F2 | $10.84 | Mar 2, 2018 | M | 12,249 | D | — | May 26, 2026 | Common Stock | 12,249 | 0 | D |
Explanation of responses
- F1The option vested as to 25% of the shares on February 25, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter.
- F2The option vested in full on May 26, 2017.